Nanobiotix S.A.'s latest marketcap:
As of 07/29/2025, Nanobiotix S.A.'s market capitalization has reached $311.3 M. According to our data, Nanobiotix S.A. is the 17579th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | $311.3 M |
Revenue (ttm) | $-8,297,979 |
Net Income (ttm) | $-78,631,141.2 |
Shares Out | 47.4 M |
EPS (ttm) | $-1.66 |
Forward PE | 0.00 |
Ex-Dividend Date | n/a |
Earnings Date | 09/18/2025 |
Nanobiotix S.A.'s yearly market capitalization.
Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
---|---|---|---|---|
07/29/2025 | €269.73 M | $311.3 M | 90.15% | 17579 |
12/31/2024 | €143.35 M | $148.4 M | -54.17% | 20806 |
12/29/2023 | €312.82 M | $345.27 M | 147.96% | 15484 |
12/30/2022 | €126.16 M | $135.02 M | -50.42% | 20384 |
12/31/2021 | €254.47 M | $289.22 M | -46.44% | 16682 |
12/31/2020 | €475.09 M | $580.26 M | 156.76% | 10815 |
12/31/2019 | €185.03 M | $207.47 M | -18.96% | 14600 |
12/31/2018 | €228.31 M | $261.78 M | -21.57% | 12551 |
12/29/2017 | €291.12 M | $349.17 M | 18.2% | 12177 |
12/30/2016 | €246.3 M | $259.01 M | 9.69% | 11785 |
Company Profile
About Nanobiotix S.A.
Nanobiotix S.A. is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer and other unmet medical needs.
Key Product Candidate
The company's lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles designed to treat various cancers, including:
- Soft tissue sarcoma
- Head and neck cancers
- Liver cancers
- Prostate cancer
- Pancreatic cancer
- Esophageal cancer
- Rectal cancer
- Non-small cell lung cancer
Strategic Partnerships
Nanobiotix has partnered with Lian Oncology Limited to develop and commercialize NBTXR3 in key Asian markets, including:
- Greater China
- South Korea
- Singapore
- Thailand
Company Background
Founded in 2003, Nanobiotix is headquartered in Paris, France.
Frequently Asked Questions
-
What is Nanobiotix S.A.'s (EPA-NANO) current market cap?As of 07/29/2025, Nanobiotix S.A. (including the parent company, if applicable) has an estimated market capitalization of $311.3 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Nanobiotix S.A. (EPA-NANO) rank globally by market cap?Nanobiotix S.A. global market capitalization ranking is approximately 17579 as of 07/29/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.